SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-038903
Filing Date
2020-03-26
Accepted
2020-03-26 17:19:28
Documents
66
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm205331-1_10q.htm 10-Q 804384
2 EXHIBIT 10.1 tm205331d1_ex10-1.htm EX-10.1 6240
3 EXHIBIT 31.1 tm205331d1_ex31-1.htm EX-31.1 10121
4 EXHIBIT 31.2 tm205331d1_ex31-2.htm EX-31.2 11183
5 EXHIBIT 32.1 tm205331d1_ex32-1.htm EX-32.1 7220
12 GRAPHIC image_001.jpg GRAPHIC 4265
13 GRAPHIC image_002.jpg GRAPHIC 5047
  Complete submission text file 0001104659-20-038903.txt   6063454

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbse-20191231.xml EX-101.INS 1760245
7 XBRL TAXONOMY EXTENSION SCHEMA nbse-20191231.xsd EX-101.SCH 34570
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbse-20191231_cal.xml EX-101.CAL 39121
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbse-20191231_def.xml EX-101.DEF 114229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20191231_lab.xml EX-101.LAB 338760
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20191231_pre.xml EX-101.PRE 279664
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 20747009
SIC: 2834 Pharmaceutical Preparations